|
ROCK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14100000453621E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82060000408768E-08 |
| Normal-vs-Stage2 |
3.447800E-04 |
| Normal-vs-Stage3 |
2.359500E-03 |
| Normal-vs-Stage4 |
4.063800E-03 |
| Stage1-vs-Stage2 |
8.725600E-01 |
| Stage1-vs-Stage3 |
6.020200E-01 |
| Stage1-vs-Stage4 |
4.288000E-01 |
| Stage2-vs-Stage3 |
5.809000E-01 |
| Stage2-vs-Stage4 |
5.015000E-01 |
| Stage3-vs-Stage4 |
2.964000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.21670000530605E-08 |
| Normal-vs-AfricanAmerican |
8.99789999952993E-07 |
| Normal-vs-Asian |
1.90931999999311E-05 |
| Caucasian-vs-AfricanAmerican |
6.739200E-01 |
| Caucasian-vs-Asian |
2.992800E-01 |
| AfricanAmerican-vs-Asian |
3.114000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.90170023961889E-10 |
| Normal-vs-Female |
3.410400E-02 |
| Male-vs-Female |
2.318800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.62770000000135E-05 |
| Normal-vs-Extreme_Weight |
1.07190001319424E-09 |
| Normal-vs-Obese |
2.41199999999608E-05 |
| Normal-vs-Extreme_Obese |
1.904350E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.685200E-01 |
| Normal_Weight-vs-Obese |
4.919400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.299200E-01 |
| Extreme_Weight-vs-Obese |
5.894500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.651000E-01 |
| Obese-vs-Extreme_Obese |
5.881800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.642600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.84529999999983E-05 |
| Normal-vs-Age(61-80Yrs) |
1.072799959978E-09 |
| Normal-vs-Age(81-100Yrs) |
1.46489999997002E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.718400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.386800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.008400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.520400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.076820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.536400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.68040001094994E-09 |
| Normal-VS-Type2 PRCC |
1.26530000033043E-07 |
| Normal-VS-KIRP CIMP |
4.055800E-01 |
| Normal-VS-Unclassified PRCC |
5.666000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.930800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.507900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.104400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.354300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.834210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.142400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.10330000269965E-09 |
| Normal-vs-N1 |
7.551800E-04 |
| Normal-vs-N2 |
3.342400E-01 |
| N0-vs-N1 |
1.824800E-01 |
| N0-vs-N2 |
6.129400E-01 |
| N1-vs-N2 |
9.227000E-01 |
|
|
